Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
US Army
Dow
Colorcon
Cerilliant
Mallinckrodt
Accenture
Medtronic
Deloitte

Generated: December 14, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 011777

« Back to Dashboard

NDA 011777 describes SODIUM PHOSPHATE P 32, which is a drug marketed by Mallinckrodt and is included in one NDA. Additional details are available on the SODIUM PHOSPHATE P 32 profile page.

The generic ingredient in SODIUM PHOSPHATE P 32 is sodium phosphate p-32. There are one thousand four hundred and fifty-four drug master file entries for this compound. Additional details are available on the sodium phosphate p-32 profile page.
Summary for 011777
Tradename:SODIUM PHOSPHATE P 32
Applicant:Mallinckrodt
Ingredient:sodium phosphate p-32
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SOLUTION;INJECTION, ORALStrength0.67mCi/ML
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:SOLUTION;INJECTION, ORALStrength1.5mCi/VIAL
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
AstraZeneca
Teva
Federal Trade Commission
Cantor Fitzgerald
Daiichi Sankyo
Harvard Business School
US Army
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.